Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data

Dermatol Ther. 2020 Jul;33(4):e13458. doi: 10.1111/dth.13458. Epub 2020 Jun 7.

Authors

Salvatore Corrao^{1

2}, Maria A Prestigiacomo¹, Rosa G Angileri¹, Giuseppe Natoli¹, Christiano Argano¹

Affiliations

¹ Department of Internal Medicine, National Relevance and High Specialization Hospital Trust A.R.N.A.S. Civico, Di Cristina, Benfratelli, Palermo, Italy.
² Università di Palermo, Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", PROMISE, Palermo, Italy.

PMID: 32319167
DOI: 10.1111/dth.13458

No abstract available

Publication types

Letter

MeSH terms

Anti-Allergic Agents* / therapeutic use
Chronic Disease
Chronic Urticaria*
Humans
Omalizumab / adverse effects
Preliminary Data
Treatment Outcome
Urticaria* / diagnosis
Urticaria* / drug therapy

Substances

Anti-Allergic Agents
Omalizumab